medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2011, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2011; 9 (2)

Cutaneous leishmaniasis. A case report

Castillo TAN, Cuevas RG, Elizondo VA, Pérez PWM

Language: Spanish
References: 17
Page: 102-106
PDF size: 461.50 Kb.


ABSTRACT

Cutaneous leishmaniasis is caused by protozoa of the gender Leishmania and the inhabitants of the south-eastern states of Mexico are frequently affected. The most common clinical form is the ulcer, and only 5% of cases involve more than one anatomical site. Pentavalents antimony salts (Sb5+) are treatment of choice for different clinical forms. We report a 34 year-old male patient, resident of Gomez Farias, Jalisco. He presented ulcerated lesions on the forehead, below his lower lip, on the neck and right forearm. The diagnosis of cutaneous leishmaniasis was made by the histological study of these lesions. A progressive resolution was obtained with intramuscular treatment with antimonial derivate Glucantime® .


REFERENCES

  1. Freederg IM, Eisen Z, Wolff K. En Fitzpatrick´s Dermatología en medicina general, 5ª ed. Tomo III. México, Editorial Médica Panamericana, 2009: 2767-2774.

  2. Solloa-Roncero ME, Magaña-Ramírez MDC, Vera-Páramo A, Moreno- Collado CA, Benuto-Aguilar RS, Zamora-Santos E. “Leishmaniasis cutánea. Experiencia en el Hospital Central militar.” Rev Sanid Milit 2001; 55(1): 10-14.

  3. Gamboa-Arend R. “Leishmaniasis cutánea (Revisión Bibliográfica).” Revista médica de Costa Rica y Centroamérica, 2009; 66(588): 169-172.

  4. Hernández-Ruiz J, Becker I. “Linfocitos T citotóxicos CD8 en la leishmaniasis cutánea”. Salud Pública de México 2006; 48(5): 430-439.

  5. Jheman-Zetina JL. “Leishmaniasis cutánea en el estado de Quintana Roo, México”. Dermatología Rev Mex 2008; 52(1): 3-9.

  6. Zegarra-Del-Carpio R, Sánchez-Saldaña L. “Leishmaniasis cutánea: presentación en placa verrucosa”. Dermatología Peruana 2005; 15(1): 62-65.

  7. Arenas R. Atlas dermatología. Diagnóstico y tratamiento. 3ª ed. México, McGraw Hill, 2005: 456-459.

  8. Hernández-Flores JDJ, Moraes-Aguirre JJ, Zamora-Chávez A. “Leishmaniasis visceral tratada con anfotericina B”. Bol Med Hosp Infant Mex 2007; 64: 43-48.

  9. Fagundo-González E, Ruiz-González I, Martínez-Fernández M, Sonsoles- Delgado V, Sánchez-Sambucety P, Rodríguez-Prieto MA. “Leishmaniasis cutánea del pabellón auricular.” Med Cutan Iber Lat Am 2005; 33(5): 219-221.

  10. Rabi-Das VN, Ali-Siddiqui N, Pandey K, Pratap-Singh V, Topno RK, et al. “A controlled, randomized nonblinded clinical trial to assess the efficacy of anfotericin B deoxicholate as compared to pentamidine for the treatment of antimony uresponsive visceral leishmaniasis cases in Bihar, India”. Therapeutics and Clinical Risk Management 2009; 5: 117-124.

  11. Moreno-Presmanes M, Tomás-Cabedo G, Valcuende-Cavero F, Pérez- Pastor G, Lázaro-Santander R. “Úlcera labial secundaria a leishmaniasis visceral en un paciente VIH-positivo”. Med Cutan Iber Lat Am 2008; 36(4): 195-198.

  12. Rondón-Lugo L. “Visión actual y futuro de la leishmaniasis”. Med Cutan Iber Lat Am 2006; 34(6): 253-254.

  13. Sánchez J, Orozco L, Buendía J, Muñoz G. “Validez del diagnóstico presuntivo de leishmaniasis cutánea realizado por mediadores comunitarios en Colombia”. Rev Panam Salud Pública 2007; 21(6): 335-334.

  14. Navarro P, Belfort E, Martín A, García J, Garrido E, Delgado O, Coraspe V, Silva S. “Evaluación terapéutica del antimoniato de meglumida en niños con leishmaniasis tegumentaria americana”. Archivos venezolanos de puericultura y pediatría 2004; 67(2): 63-66.

  15. Asilian A, Jalayer T, Nilforooshzadeh M, Peto R, Wayling S, et al. “Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran”. Bulletin of the World Health Organization 2003; 81(5). 353-359.

  16. Passos V, Barreto S, Romanha A, Krettli A, Volpini A, Lima-e-Costa MF. “American cutaneous leishmaniasis: use of a skin test as predictor of relapse after teatment”. Bulletin of de World Health Organization 2000; 78(8): 968-974.

  17. Ben-Salah A, Kamarianakis Y, Chlif S, Ben-Alaya N, Prastacos P. “Zoonotic cutaneous leishaniasis in central Tunisia: spatio-temporal dynamics”. International Journal of Epidemiolog 2007; 36: 991-1000.




2020     |     www.medigraphic.com